Navigation Links
Pharmacyclics Reports Second Quarter 2014 Results
Date:7/31/2014

ks signals that tell malignant B-cells to multiply and spread uncontrollably. It is one of the first medicines to file for FDA approval via the new Breakthrough Therapy Designation pathway, and is the recipient of three Breakthrough Therapy Designations for various indications. To date, 11 Phase III trials have been initiated with IMBRUVICA and 43 trials are currently registered on www.clinicaltrials.gov. Janssen and Pharmacyclics entered into a collaboration and license agreement in December 2011 to co-develop and co-commercialize IMBRUVICA.

For more information about IMBRUVICA, including the full prescribing information, please visit www.IMBRUVICA.com.

Access to IMBRUVICAPatients who are prescribed IMBRUVICA can receive access support through several distinct programs:

  • The YOU&i Start™ program enables eligible patients who have been prescribed IMBRUVICA for an FDA-approved indication and are experiencing insurance coverage delays to access free product for a limited period of time, if they meet certain requirements. In addition, our YOU&i Access service center is set up to help patients ensure that all access-related administration is properly handled.
  • The YOU&i Access™ Instant Savings Program helps commercially insured patients who have difficulties with out-of-pocket expenses for IMBRUVICA. Eligible patients may receive support to reduce their monthly out-of-pocket costs to $10, effective August 1, 2014.
  • Patients who are deemed uninsured and eligible, and who qualify based on financial need, can access IMBRUVICA through the Johnson & Johnson Patient Assistance Foundation (JJPAF), an independent non-profit organization to which Pharmacyclics makes donations.
  • Pharmacyclics will also support third party foundations, organizations and other efforts to help patients in need get access to appropriate c
    '/>"/>

  • SOURCE Pharmacyclics, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

    Related medicine technology :

    1. Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014
    2. Pharmacyclics Announces Data Presentations for Ibrutinib in B-Cell Malignancies
    3. WuXi PharmaTech to Partner with Pharmacyclics
    4. Pharmacyclics Reports Third Quarter 2013 Results
    5. Pharmacyclics Announces Date of Conference call to discuss Financial Results for Third Quarter Ended September 30, 2013
    6. Pharmacyclics Reports Second Quarter 2013 Results
    7. Pharmacyclics Announces Date of Financial Results for Second Quarter Ended June 30, 2013 and Conference Call
    8. Pharmacyclics Reports First Quarter 2013 Results
    9. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
    10. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
    11. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/19/2014)... CARDIFF-BY-THE-SEA, Calif. , Dec. 19, ... SRNE ;  Sorrento), an oncology company developing new ... Inc., a privately-held immuno-oncology company developing proprietary Neukoplast ... based therapy, announced today that the companies have ... next generation CAR-TNK™ (pronounced as "Car-Tank") immunotherapies for ...
    (Date:12/19/2014)... 18, 2014  Decision Resources Group finds that the ... will increase to a value of over ... by expansion in the large direct energy device market. ... increasingly adopted due to the advantages they offer and ... findings from Decision Resources Group,s coverage of the U.S. ...
    (Date:12/19/2014)... , Dec. 18, 2014   Aratana Therapeutics, ... biopharmaceutical company focused on the licensing, development and ... announced positive results from its pivotal field study ... treating pain in dogs with osteoarthritis.  In the ... assessment scores that were statistically significant compared to ...
    Breaking Medicine Technology:Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5
    ... Development for Chronic Pain and Non-Pain ... Indications -, ... ) today announced that data from its multiple dose clinical,trial of tezampanel, ... the product candidate is safe and,well-tolerated in normal male and female subjects., ...
    ... Show PTC124 Addresses Underlying Cause of Genetic Disorders and ... Protein Function in Cystic Fibrosis Model, SOUTH PLAINFIELD, N.J., ... new preclinical data in the February 12,2008 edition of the ... PTC124, a novel drug designed to bypass nonsense mutations,was active ...
    Cached Medicine Technology:Multiple Dose Clinical Trial of TorreyPines Therapeutics' Tezampanel Demonstrates Compound is Safe and Well-Tolerated 2Multiple Dose Clinical Trial of TorreyPines Therapeutics' Tezampanel Demonstrates Compound is Safe and Well-Tolerated 3Multiple Dose Clinical Trial of TorreyPines Therapeutics' Tezampanel Demonstrates Compound is Safe and Well-Tolerated 4PTC Therapeutics Announces Publication of Preclinical Data in PNAS 2PTC Therapeutics Announces Publication of Preclinical Data in PNAS 3PTC Therapeutics Announces Publication of Preclinical Data in PNAS 4
    (Date:12/22/2014)... As part of a company-wide ... in San Diego and surrounding areas, Golden ... care team with ongoing online training courses. , ... provided by Caregiverlist®. Caregiverlist® is “the premiere ... most reliable eldercare options, highest quality ratings and ...
    (Date:12/22/2014)... December 22, 2014 Fad diets ... The reason why most fad diets have hung around ... problem with fad diets is that, as the body becomes ... dieter uncertain of how to reset the metabolism to return ... Diet Doc developed their all-inclusive diet plans that ...
    (Date:12/22/2014)... LENEXA, Kan. (PRWEB) December 22, 2014 ... it will add a subscription option to their ad ... for report writing services. Customers can sign up for ... report writing hours each month at a deeply discounted ... pricing tiers, and each has a progressively discounted rate. ...
    (Date:12/22/2014)... (PRWEB) December 22, 2014 On December ... joined by Pastor Gordon Cashwell for an episode to ... asks Gordon, “Why is it so important to you ... Jesus?” Cashwell replies, “We all should respect who Jesus ... was founded on Christian beliefs. That means that on ...
    (Date:12/22/2014)... Harrisburg, NC (PRWEB) December 22, 2014 ... contain the current Ebola virus epidemic are ... by U.S. government agencies, nongovernmental organizations (NGOs) ... solutions remains ongoing, healthcare workers, emergency responders, ... advanced technologies such as the CmTP ...
    Breaking Medicine News(10 mins):Health News:Golden Care Partners with Nationally Recognized Caregiver Training Service 2Health News:Diet Doc Announces the Difference Between Fad Diets and Real Weight Loss Programs to Help Dieters Make the Best Choice 2Health News:Diet Doc Announces the Difference Between Fad Diets and Real Weight Loss Programs to Help Dieters Make the Best Choice 3Health News:Diet Doc Announces the Difference Between Fad Diets and Real Weight Loss Programs to Help Dieters Make the Best Choice 4Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 2Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 3Health News:My Positive Perspective Celebrates Christmas With an Event to Celebrate the Birthday of Jesus 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 4Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 5
    ... Expands Coty-DKMS: Linked Against Leukemia PartnershipWARSAW, Poland, Feb. 25 ... industry and the world,s largest fragrance company, and DKMS, ... pleased to announce the opening of DKMS Polska, the ... global initiative. DKMS was inspired by Coty to open ...
    ... Feb. 25 In a unified effort to ... in Michigan, MidMichigan Health will go trans fat ... fats will be eliminated from patient meals, cafeteria ... shelves at MidMichigan Medical Centers in Alma, Clare, ...
    ... Mark Leventhal, Esq., the Founder and President of Leventhal ... executive weight loss consulting service for attorneys by an ... Association at 11:45 am today at Hellriegel,s Inn, 1840 ... a one-on-one personalized approach, and works with clients over ...
    ... Healthtech Institute, has announced the release of IND Submissions: A Primer, ... IND and applicable IND amendments. IND Submissions: A Primer is the ... ... Needham, MA (PRWEB) February 25, 2009 -- IND Submissions: A Primer ...
    ... physical activity and encourages healthy lifestylesWESTMINSTER, Colo., Feb. ... Westminster, CO, can now earn an extra $500 ... new health and wellness program, Virgin HealthMiles. Offered ... incentivizes and rewards healthy goals such as exercising, ...
    ... L.U.V. (Loyal, United, Vocal) Program encourages parents across the country ... Week February 22-28 "I found a note ... home from school. It said, ,I know you have ... TEEN ON-LINE CHAT FORUM)PHILADELPHIA, Feb. 25 Finding the right ...
    Cached Medicine News:Health News:Coty Inc. and DKMS Announce the Opening of DKMS Polska 2Health News:Coty Inc. and DKMS Announce the Opening of DKMS Polska 3Health News:MidMichigan Health Cuts Out Trans Fats Beginning March 1 2Health News:Mark Leventhal to Address the Lake County (OH) Bar Association 2Health News:Barnett Releases IND Submissions: A Primer 2Health News:Barnett Releases IND Submissions: A Primer 3Health News:Barnett Releases IND Submissions: A Primer 4Health News:Dalbey Education Launches Health and Wellness Program 2Health News:The Renfrew Center Foundation Partners with 2008 Miss America Kirsten Haglund and Her Mom, Iora Haglund, to Empower Parents to Fight Eating Disorders 2Health News:The Renfrew Center Foundation Partners with 2008 Miss America Kirsten Haglund and Her Mom, Iora Haglund, to Empower Parents to Fight Eating Disorders 3
    ... a large body for increased stability ... centimeters center-to-center) to resist the wear ... indicators are molded into the body. ... bar electrode styles. Shielded bar electrodes ...
    ... Cadwell's custom bars have a ... solid, machined contacts (spaced 3 centimeters ... tear of repeated cleaning. Polarity indicators ... convenient, snap-on handle fits our bar ...
    The Surgifresh mini has the same rugged construction as the Plume-inator. It is the ideal size for operating room, clinic and office settings. This unit includes a filter test button, hospital grade ...
    ... Evolutionary refractive lens technology for ... safety and efficacy, demonstrates quality of ... contact lens correction. The lens is ... and is now available for the ...
    Medicine Products: